Urogenital trichomoniasis, unspecified
ICD-10 A59.00 is a billable code used to indicate a diagnosis of urogenital trichomoniasis, unspecified.
Urogenital trichomoniasis is a sexually transmitted infection caused by the protozoan parasite Trichomonas vaginalis. It primarily affects the urogenital tract, leading to symptoms such as vaginal discharge, itching, and discomfort in women, while men may experience urethral discharge and irritation. However, many individuals remain asymptomatic, which complicates diagnosis and increases the risk of transmission. The infection is typically transmitted through sexual contact, making it crucial for healthcare providers to conduct thorough sexual histories and consider contact tracing for partners. Diagnosis is often confirmed through laboratory testing, including wet mount microscopy or nucleic acid amplification tests (NAATs). Treatment usually involves the administration of metronidazole or tinidazole, with recommendations for both the infected individual and their sexual partners to prevent reinfection. Given the potential for asymptomatic cases, routine screening in high-risk populations is advised. Proper education on safe sexual practices is essential to reduce the incidence of this infection.
Detailed patient history, including sexual history and symptomatology.
Diagnosis and management of STIs, including contact tracing.
Consideration of co-infections and comprehensive treatment plans.
Documentation of gynecological exams, lab results, and treatment plans.
Management of vaginal infections and routine STI screenings.
Importance of discussing sexual health and safe practices with patients.
Used for confirming diagnosis in symptomatic or asymptomatic patients.
Document the reason for testing and patient symptoms.
Infectious disease specialists may require additional lab results.
The primary treatment for urogenital trichomoniasis is metronidazole or tinidazole, which should be administered to both the infected individual and their sexual partners.
